Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction
As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....
235 Views
New Features on Samsung's GS8 & Possible Beneficiaries in Samsung Ecosystem
WSJ reported that Samsung's GS8 will likely be released as late as April next year instead of next year's MWC (February). Traditionally, Samsung...
676 Views
Huawei Might Be the Next One See Y/Y Decline After Apple and Xiaomi in China
Summary What's new? Strategy Analytics reported China smartphone shipments grew 15% y/y and 11% q/q to 121mn units in 3Q16 and Huawei maintained...
325 Views
Samsung's Top & Backup Options for Restructuring - Prediction on Its Response to Elliott
Korea's Fair Trade Commission official (Kim Jung-ki) has officially said last week (Nov 1) that FTC would submit an amendment to the current fair...
213 Views
Positive Catalysts Ahead, Structural Story Intact; Buy Samsung
Focus on shareholder returns policy, structural 'storage' led growth; valuations still compelling after Note 7 discontinuation, recommend...
184 Views